Advertisement
Home Tags Vaccines

Tag: Vaccines

Health insurance companies are expected to cover vaccines for the new coronavirus without charging copays

U.S. Insurers Should Not Charge Copays for COVID-19 Vaccine

0
Government has been in discussions with insurers about covering COVID-19 vaccination at no cost to patients
About 6.1 percent of parents are hesitant about routine childhood vaccines

More Than One in Four Parents Hesitant About Flu Vaccine

0
Seventy and 26 percent strongly agree that routine and flu vaccines are effective, respectively
Oral polio vaccines might provide temporary protection against the new coronavirus while scientists try to develop a vaccine to fight COVID-19 infection

Oral Polio Vaccines Might Protect Against New Coronavirus

0
Since poliovirus and coronavirus are positive-strand RNA viruses, they may induce common innate immunity mechanisms
A large clinical trial of the first U.S. COVID-19 vaccine could begin next month

First Large Clinical Trial of COVID-19 Vaccine in U.S. Could Begin in July

0
Trial will assess effectiveness of vaccine, include 30,000 volunteers who will receive either vaccine or placebo
A partnership that would bypass the drug industry to sell a potential vaccine against the new coronavirus has been formed by a laboratory at Imperial College London.

Partnership Would Bypass Drug Industry to Sell COVID-19 Vaccine

0
Vaccine could be sold without profits or licensing fees in Britain and low- and middle-income countries
Francis Collins

NIH Head Fears Some Will Bypass a COVID-19 Vaccine

0
Name of campaign -- 'Operation Warp Speed' -- does not mean corners will be cut on safety
According to Anthony Fauci

Fauci Says Any COVID-19 Vaccine Would Be in Plentiful Supply by 2021

0
Plan is to make doses of the vaccine before it is known to work, so if it does work, it can be distributed quickly
A recombinant adenovirus type-5 vectored COVID-19 vaccine is safe

Adenovirus Type-5 Vectored COVID-19 Vaccine Shows Promise

0
ELISA antibodies and neutralizing antibodies increased at day 14, peaked at day 28
The U.S. Department of Health and Human Services said Thursday it would provide up to $1.2 billion to AstraZeneca to develop a potential COVID-19 vaccine from a lab in Oxford

U.S. Offers $1.2 Billion to Drug Company for COVID-19 Vaccine Research

0
Deal will fund phase 3 clinical trial in the United States this summer with about 30,000 volunteers
There has been a decrease in child vaccination coverage in almost all milestone age cohorts during the COVID-19 pandemic

Decrease Seen in Child Vaccination Coverage During COVID-19

0
Up-to-date status for all recommended vaccines down to 49.7 percent among children aged 5 months